Product Images Mesalamine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Mesalamine NDC 68382-452 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image - 3ef2b141 9ef9 4363 9c5b f70274e00d37 01

Image - 3ef2b141 9ef9 4363 9c5b f70274e00d37 01

image - 3ef2b141 9ef9 4363 9c5b f70274e00d37 02

image - 3ef2b141 9ef9 4363 9c5b f70274e00d37 02

This is a description of Mesalamine extended-release capsules, USP containing 120 capsules with each capsule containing mesalamine, USP 0.375 g. The usual dosage is available in the package insert for full prescribing information. The package is child-resistant and should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). It is manufactured by Cadila Healthcare Ltd. in Ahmedabad, India and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ 08534. It is important to keep this and all drugs out of reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.